Answers are grounded in this paper and cite their sources.
A double-blind study of 18 children aged 6--12 years suffering from primary nocturnal enuresis without signs of underlying organic disease is reported. 20 microgram of DDAVP (desamino-D-arginine vasopressin, Minirin) was given intranasally at bedtime. The effect was prompt and satisfactory in 8 children and relatively good in another 8 children. No adverse effects were noted. DDAVP is advocated for temporary use in children with nocturnal enuresis needing immediate help.
No takes yet. Share an insight, caveat, or question.
Torsten Tuvemo (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: